Aaron Carter Estate Reaches Settlement With Walgreens Over Xanax Prescriptions

The estate of late pop singer Aaron Carter has reached a confidential settlement with Walgreens and Santa Monica Medical Plaza Pharmacy in a lawsuit stemming from his 2022 death. The agreement resolves all claims against the two pharmacy entities but does not affect ongoing legal actions involving other defendants.

Aaron Carter, who rose to fame as a child star in the late 1990s and early 2000s, was found deceased in his Lancaster, California home in November 2022 under circumstances linked to drug use. His former fiancée filed a wrongful death lawsuit on behalf of their young son, Princeton Lyric Carter, who is also the sole heir to Aaron’s estate.

The legal battle has centered on allegations that Carter was prescribed Xanax in excessive and frequent amounts by medical professionals and that pharmacies including Walgreens and Santa Monica Medical Plaza Pharmacy facilitated these prescriptions. Plaintiffs argued that this overprescribing contributed to Carter’s fatal drowning.

Prior to the settlement with the pharmacy defendants, the estate had also reached a resolution with Dr. John Faber of Amen Clinics. This earlier settlement included a payment of an undisclosed sum and was subject to statutory limits on non-economic damages under California’s Medical Injury Compensation Reform Act (MICRA). Faber’s legal team contested claims that his treatment caused Carter’s death, attributing it instead to inhalation of difluoroethane.

The recent settlement with the pharmacies was confirmed through court documents obtained by Rolling Stone. Though the financial terms remain confidential, the estate’s legal representative expressed satisfaction in resolving the dispute for the benefit of Carter’s minor son. Walgreens and the Santa Monica pharmacy declined to comment on the matter.

Aaron Carter’s career began with his debut album in 1997, which propelled him into international recognition as a child artist. Subsequent releases such as the platinum-certified Aaron’s Party (Come Get It) in 2000 and follow-up albums through the early 2000s solidified his presence in the pop music landscape. His final album, Love, was released in 2018.

The wrongful death lawsuit has highlighted ongoing concerns about prescription practices and their role in the opioid and benzodiazepine crises affecting numerous individuals in the entertainment industry and beyond. Carter’s case has drawn attention to the complexities of medical responsibility and pharmaceutical accountability.

While the settlements with pharmacies and one physician mark significant developments, claims against other medical professionals involved remain unresolved. The estate continues to pursue these avenues in seeking justice and accountability related to the circumstances of Aaron Carter’s untimely passing.

This progression in the legal proceedings underscores the challenges faced by families of public figures grappling with the aftermath of substance-related deaths. It also reflects the broader legal landscape where healthcare providers and pharmacies are increasingly scrutinized for their roles in prescription drug misuse and its consequences.

As these developments unfold, the music community remembers Aaron Carter not only for his youthful stardom but also as a cautionary figure whose struggles have sparked important conversations about health, responsibility, and legacy.